Publications Office of the EU
Spain-Madrid: Vaccines - EU tenders
DisplayCustomHeader
Procurement Detail Actions Portlet
OP Portal - Procurement - Details

Spain-Madrid: Vaccines

  • Awarded
    22/12/2021
  • Today
    17/08/2026
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
CONSEJERÍA DE SANIDAD DE LA COMUNIDAD DE MADRID
Place of performance
NUTS code: ES300 Madrid
Location of buyer
NUTS code: ES300 Madrid
Business sector (Main CPV)
33651600 Vaccines
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
35,160,387.75 EUR
Tender reference number
73/2021 (A/SUM-037851/2021)
Description

Este contrato tiene por objeto la adquisición de 251.730 dosis de la vacuna frente al herpes zoster para el último trimestre de 2021 y el ejercicio 2022, para la vacunación de personas pertenecientes a grupos de riesgo consensuados a nivel nacional para esta enfermedad, de acuerdo a la asignación del Ministerio de Sanidad para la Comunidad de Madrid.
Por tratarse de suministros contemplados en el artículo 16.3.a) de la Ley de Contratos del Sector Público, las cantidades propuestas para la adjudicación son estimadas y su entrega está condicionada a las necesidades de la Dirección General de Salud Pública.

Submission Method
Not available
Tenders may be submitted
Not applicable
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
Not available
Place of performance
Award method
Lowest price
Estimated value
Not available
Final contracted value
35,160,387.75 EUR
Award of contract
Official name: Glaxosmithkline, S.A.
Postal address:
Town: Madrid
Postal code:
Country: ESP
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.